- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: BMS-833923 (XL139)
Total 3157 results
-
Bristol-Myers SquibbCompletedHepatitis CUnited States, Australia, Canada, France, Puerto Rico
-
Bristol-Myers SquibbCompletedType 2 DiabetesRussian Federation
-
Bristol-Myers SquibbTerminatedCarcinoma, HepatocellularChina, Korea, Republic of, Taiwan, Singapore
-
H. Lee Moffitt Cancer Center and Research InstituteNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Northwestern UniversityNational Cancer Institute (NCI)Active, not recruiting
-
The Netherlands Cancer InstituteCompletedHead and Neck Neoplasms | ImmunotherapyNetherlands
-
Bristol-Myers SquibbCompletedMelanomaBelgium, Brazil, United States, Canada, Spain, Greece, France, United Kingdom, Australia, Italy, Austria, Switzerland, Germany, Israel, Russian Federation, Romania, Czechia, Poland, New Zealand
-
Bristol-Myers SquibbCompleted
-
Bristol-Myers SquibbTerminatedHealthy Adult VolunteersUnited States
-
Bristol-Myers SquibbWithdrawnStage III or IV Melanoma
-
Bristol-Myers SquibbActive, not recruitingNeoplasms by SiteUnited States, Mexico, Italy, Argentina, Brazil, Chile, France, Netherlands, New Zealand, Poland, Spain, United Kingdom
-
National Cancer Institute (NCI)NRG OncologyCompletedRecurrent Uterine Corpus Sarcoma | Uterine Corpus LeiomyosarcomaUnited States
-
PfizerBristol-Myers SquibbRecruiting
-
Bristol-Myers SquibbRecruitingHeart FailureUnited States, Spain, Canada, Italy, Poland
-
CelgeneRecruitingPrimary Myelofibrosis | Myeloproliferative Disorders | Anemia | Myelofibrosis | Post-Polycythemia Vera MyelofibrosisFrance, Belgium, Spain, Australia, Canada, United States, Korea, Republic of, Romania, Japan, Israel, Italy, Austria, China, Czechia, Germany, Greece, Ireland, Poland, United Kingdom, Hong Kong, Hungary, Lebanon, Argentina, Chile, Colombia and more
-
Bristol-Myers SquibbActive, not recruitingCardiomyopathy, Hypertrophic ObstructiveJapan
-
Bristol-Myers SquibbCompleted
-
Bristol-Myers SquibbCompletedA Study to Evaluate the Effects on the Single-Dose Drug Levels of Mavacamten in Healthy ParticipantsHealthy ParticipantsUnited States
-
Bristol-Myers SquibbCompletedFollicular Lymphoma | Chronic Lymphocytic Leukemia | Acute Myelogenous Leukemia | Diffuse Large B-Cell LeukemiaUnited States
-
Bristol-Myers SquibbNektar TherapeuticsCompletedBladder Cancer | Bladder Tumor | Muscle-Invasive Bladder CancerRussian Federation, China, Germany, Italy, United States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Czechia, France, Greece, Israel, Mexico, Netherlands, Poland, Spain, United Kingdom
-
Bristol-Myers SquibbTerminatedHealthy Volunteers | Ulcerative ColitisAustralia, Georgia, Moldova, Republic of
-
Bristol-Myers SquibbCompletedCANCER,NOSFrance, Canada, United States, Switzerland, Spain, Italy
-
Bristol-Myers SquibbTerminatedTumorItaly, United States, New Zealand
-
Bristol-Myers SquibbMedarex; Ono Pharma USA IncCompleted
-
Bristol-Myers SquibbWithdrawnNon-Small Cell Lung Cancer | Lung CancerItaly, Korea, Republic of, Turkey, Canada, Spain, Australia, Mexico, Taiwan, France, Germany, Switzerland, Greece, Japan, Austria, United States, Brazil, Czechia
-
Bispebjerg HospitalNot yet recruitingBariatric Surgery Candidate | Prosthesis-Related Infections | Prosthesis Failure | Prosthesis Survival | Arthritis Knee
-
Hospital for Special Surgery, New YorkCompletedOsteoarthritis, KneeUnited States
-
CelgeneAcceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway...RecruitingBeta-ThalassemiaUnited States, Turkey, Italy, Thailand, Germany, Greece, China, India, Lebanon
-
Bristol-Myers SquibbTerminatedPrimary Familial Dilated CardiomyopathyUnited States, Germany, Spain, United Kingdom
-
Boehringer IngelheimCompleted
-
Bristol-Myers SquibbCompletedChronic Hepatitis C Virus Infection | Chronic Hepatitis B Virus InfectionUnited States
-
Bristol-Myers SquibbCompletedHealthy ParticipantsUnited States
-
Bristol-Myers SquibbCompleted
-
Boehringer IngelheimCompleted
-
Riphah International UniversityCompleted
-
University of MichiganNational Institute on Drug Abuse (NIDA)Completed
-
Bristol-Myers SquibbCompleted
-
Xuanwu Hospital, BeijingCompleted
-
Bristol-Myers SquibbCompletedMelanomaFrance, Italy, United States, Germany, Canada, Denmark
-
Bristol-Myers SquibbActive, not recruitingHepatocellular Carcinoma | Hepatoma | Liver Cell Carcinoma | Liver Cancer, Adult | Liver Cell Carcinoma, AdultChile, Brazil, Argentina, China, Czechia, France, Hong Kong, Japan, Korea, Republic of, Mexico, New Zealand, Poland, Romania, Singapore, Spain, Taiwan, Turkey
-
Robert R. McWilliams, MDBristol-Myers Squibb; Hoosier Cancer Research NetworkActive, not recruiting
-
ViiV HealthcareGlaxoSmithKlineTerminatedInfection, Human Immunodeficiency VirusUnited States
-
Bristol-Myers SquibbActive, not recruitingCardiomyopathy, HypertrophicSpain, Austria, Belgium, Brazil, Canada, Denmark, France, Germany, Hungary, Israel, Japan, Netherlands, Norway, Poland, Portugal, United Kingdom, United States, Australia, China, Czechia, India, Italy, Korea, Republic of
-
Bristol-Myers SquibbCompletedHealthy VolunteersUnited States
-
LianBio LLCActive, not recruitingObstructive Hypertrophic CardiomyopathyChina
-
Bristol-Myers SquibbCompletedHepatocellular CarcinomaUnited States, Argentina, Australia, Canada, China, France, Hong Kong, Italy, Japan, Korea, Republic of, Taiwan, Thailand, Spain
-
Radboud University Medical CenterBristol-Myers SquibbActive, not recruitingProstatic Neoplasms, Castration-ResistantNetherlands
-
Kristen GanjooBristol-Myers SquibbCompletedSoft Tissue SarcomaUnited States
-
ExelixisActive, not recruitingRenal Cell CarcinomaUnited States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, Czechia, Finland, France, Germany, Hong Kong, Hungary, Israel, Italy, Korea, Republic of, Mexico, Netherlands, New Zealand, Poland, Singapore, Spain, Taiwan, United...